- Home
- ALLR vs NITO Comparison
ALLR vs NITO Comparison
Compare ALLR & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- NITO
- Stock Information
- Founded
- ALLR 2004
- NITO 2009
- Country
- ALLR United States
- NITO Israel
- Employees
- ALLR N/A
- NITO N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- NITO
- Sector
- ALLR Health Care
- NITO
- Exchange
- ALLR Nasdaq
- NITO NYSE
- Market Cap
- ALLR 4.0M
- NITO 4.2M
- IPO Year
- ALLR N/A
- NITO N/A
- Fundamental
- Price
- ALLR $0.85
- NITO $0.30
- Analyst Decision
- ALLR
- NITO
- Analyst Count
- ALLR 0
- NITO 0
- Target Price
- ALLR N/A
- NITO N/A
- AVG Volume (30 Days)
- ALLR 564.1K
- NITO 5.5M
- Earning Date
- ALLR 08-04-2025
- NITO 05-15-2025
- Dividend Yield
- ALLR N/A
- NITO N/A
- EPS Growth
- ALLR N/A
- NITO N/A
- EPS
- ALLR N/A
- NITO N/A
- Revenue
- ALLR N/A
- NITO $232,000.00
- Revenue This Year
- ALLR N/A
- NITO N/A
- Revenue Next Year
- ALLR N/A
- NITO N/A
- P/E Ratio
- ALLR N/A
- NITO N/A
- Revenue Growth
- ALLR N/A
- NITO 24.74
- 52 Week Low
- ALLR $0.61
- NITO $0.16
- 52 Week High
- ALLR $17.35
- NITO $3.49
- Technical
- Relative Strength Index (RSI)
- ALLR 39.03
- NITO 49.96
- Support Level
- ALLR $0.78
- NITO $0.25
- Resistance Level
- ALLR $0.93
- NITO $0.30
- Average True Range (ATR)
- ALLR 0.07
- NITO 0.03
- MACD
- ALLR -0.02
- NITO -0.00
- Stochastic Oscillator
- ALLR 18.72
- NITO 67.66
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.